Ensaio biomecânico para determinação do diâmetro de barra conectora de polimetilmetacrilato em fixador esquelético externo tipo Ia no úmero de suínos / Biomechanical test to determination the diameter of the polymethylmethacrylate bar in external skeletal fixator type Ia in swine humerusi

Fraturas ósseas podem ser corrigidas com a utilização de fixadores esqueléticos externos (FEE), método de estabilização bastante comum. Para tanto, têm-se utilizado barras conectoras de polimetilmetacrilato (PMMA) sem critério de diâmetro, as quais podem quebrar, se ficarem muito delgadas, ou ocasionar incômodo, quando muito pesadas e volumosas. O objetivo deste trabalho foi testar, por meio de ensaio biomecânico de compressão axial e flexão, qual é o diâmetro ideal da barra conectora de PMMA, correlacionado com o diâmetro ósseo para utilização em FEE tipo Ia. Utilizaram-se 24 úmeros para se realizarem medidas de comprimento, diâmetro, circunferência e ensaios biomecânicos. Após, foram confeccionadas barras de 1,5 vezes a média do diâmetro ósseo (grupo I), do mesmo diâmetro ósseo (grupo II) e de 0,5 vezes o diâmetro (grupo III). Com os resultados obtidos ao se compararem os valores dos ossos com os dos grupos II e III, verificou-se que as barras conectoras do grupo II mostraram-se mais resistentes do que o tecido ósseo no ensaio de compressão. No ensaio de flexão, os ossos resistiram mais quando comparados aos grupos II e III, sendo 4,3 vezes mais resistentes do que o grupo III nesse mesmo ensaio mecânico. Os resultados permitem um direcionamento para confecção de barras considerando-se o diâmetro ósseo como referência.(AU)

Bone fractures can be corrected from external skeletal fixators (ESF) in a fairly common internal stabilization method, in which connector bars polymethylmethacrylate (PMMA) is used. PMMA is used without criterion of diameter, and it can break if it is too thin or too heavy. It can be uncomfortable when bulky. The aim of this study was to test, through biomechanical axial compression and bending which is the ideal connector bar diameter PMMA, correlated to bone diameter for use in type Ia ESF. Twenty-four humerus were used to make measurements of length, diameter, circumference, and biomechanical testing. After the bars confected with 1.5 times the average diameter of the bone (group I), the same diameter (group II) and 0.5 times the diameter of the bone (group III). With the obtained results, using GII and GIII results, it was observed that the connector bars in group II were more resistant than the bones in the compression test. In the bending test, the bones resisted flexion strength when compared to group III and the group II was 4.3 times more resistant than group III in the same mechanical test. The results allow a direction for making bars considering bone diameter as a reference.(AU)

Laparoscopic repair of congenital pleuroperitoneal hernia using a polypropylene mesh in a dog / Correção laparoscópica de hérnia pleuroperitoneal utilizando malha de polipropileno em cão

Pleuroperitoneal hernias are the most uncommon type of diaphragmatic hernias in dogs and cats. The treatment of choice is surgery and may involve the use of prosthetic implant through celiotomy. In the current report, laparoscopic repair of a congenital pleuroperitoneal hernia using polypropylene mesh in a dog is described. The surgery was feasible. Appropriate reduction of the hernia was carried out and no complications were noted.

Hérnias pleuroperitoneais são o tipo mais incomum de hérnias diafragmáticas em cães e gatos. O tratamento de escolha é cirúrgico e pode envolver o uso de implantes protéticos na abordagem via laparotomia. No presente relato, é descrito o reparo de uma hérnia pleuroperitoneal congênita através de laparoscopia com utilização de malha de polipropileno. A cirurgia foi viável. Houve redução apropriada da hérnia sem observação de complicações.

The first total synthesis of a highly branched arabinofuranosyl hexasaccharide found at the nonreducing termini of mycobacterial arabinogalactan and lipoarabinomannan.

[reaction--see text] The first total synthesis of the arabinofuranosyl hexasaccharide present at the nonreducing termini of mycobacterial arabinogalactan and lipoarabinomannan is reported. The oligosaccharide was prepared as its methyl glycoside via a route that is both highly efficient and convergent. Addition of two beta-D-arabinofuranosyl residues simultaneously in high yield and with excellent stereocontrol was the key step of the synthesis.

Catalytic mechanism of Kdo8P synthase: transient kinetic studies and evaluation of a putative reaction intermediate.

The mechanistic pathway for the reaction catalyzed by Kdo8P synthase has been investigated, and the cyclic bisphosphate 2 has been examined as a putative reaction intermediate. Two parallel approaches were used: (1) chemical synthesis of 2 and evaluation as an alternate substrate for the enzyme and (2) transient kinetic studies using rapid chemical quench methodology to provide direct observation and characterization of putative intermediate(s) during enzyme catalysis. The putative cyclic bisphosphate intermediate 2, possessing the stereochemistry of the beta-pyranose form, was synthesized and evaluated as a substrate and as an inhibitor of Kdo8P synthase. The substrate activity was examined by monitoring the release of anomeric phosphate over time using proton-decoupled 31P NMR spectroscopy. A very similar time course for the formation of inorganic phosphate was found in each experiment and the corresponding control experiment; i.e., no enzyme-catalyzed acceleration in the anomeric phosphate hydrolysis was detected. It was found however that 2 binds to the enzyme and is a competitive inhibitor with respect to phosphoenolpyruvate binding, having a Ki value of 35 microM. In a parallel study, we have performed single-turnover rapid chemical quench experiments to examine both the forward and reverse directions to identify a putative enzyme intermediate(s). Our results clearly demonstrate that the cyclic bisphosphate intermediate 2 does not accumulate under single-enzyme turnover conditions. This observation, coupled with the results obtained through the evaluation of synthetic 2 as a substrate, strongly suggests that the Kdo8P synthase catalytic pathway does not involve the formation of 2 as a reaction intermediate. Taken together, these combined results support the original hypothesis [Hedstrom, L., and Abeles, R. H. (1988) Biochem. Biophys. Res. Commun. 157, 816-820], which suggests a reaction pathway involving an acyclic bisphosphate intermediate 1.

Synthesis of carboxyl-reduced analogues related to the Chlamydia-specific Kdo trisaccharide epitope.

The disaccharides allyl O-(sodium 3-deoxy-alpha-D-manno-2-octulopyranosylonate)-(2-->4)-3-deoxy-a lph a-D- manno-2-octulopyranoside (8), allyl O-(3-deoxy-alpha-D-manno-2-octulopyranosyl)-(2-->8)-(sodium 3-deoxy-alpha-D-manno-2-octulopyranosidonate) (24), and allyl O-(sodium 3-deoxy-alpha-D-manno-2-octulopyranosylonate)-(2-->8)-3-deoxy-a lph a-D- manno-2-octulopyranoside (35), and the trisaccharides allyl O-(sodium 3-deoxy-alpha-D-manno-2-octulopyranosylonate)-(2-->8)-(sodium 3-deoxy-alpha-D-manno-2-octulopyranosylonate)-(2-->4)-3-deoxy-a lph a-D-manno-2-octulopyranoside (13) and allyl O-(3-deoxy-alpha-D-manno-2-octulopyranosyl)-(2-->8)-(sodium 3-deoxy-alpha-D-manno-2-octulopyranosylonate)-(2-->4)-(sodium 3-deoxy-alpha-D-manno-2-octulopyranosidonate) (30) were prepared. The ketosidic linkages were formed in good yields and high stereoselectivity by BF3 . Et2O-catalyzed reaction of the per-O-acetylated 3-deoxy-alpha-D-manno-2-octulopyranosyl fluoride derivative (16) with 8-O-SiButMe2 derivatives 19 and 21. Coupling reactions using the Kdo monosaccharide bromide derivative 4 or the alpha-(2-->8)-linked Kdo disaccharide bromide derivatives 9 and 26 were performed under Helferich conditions in MeCN or MeNO2, respectively. The disaccharide halides were prepared in good overall yields starting from the readily available allyl beta-glycoside of Kdo. The deprotected oligosaccharides correspond to the genus-specific lipopolysaccharide epitope of Chlamydia and part structures thereof, containing the carboxyl-reduced Kdo-residues at the distal and proximal position of the Kdo trisaccharide epitope, respectively.